These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 15131258

  • 21. Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.
    Colin S, Bourguignon E, Boullay AB, Tousaint JJ, Huet S, Caira F, Staels B, Lestavel S, Lobaccaro JM, Delerive P.
    Endocrinology; 2008 Oct; 149(10):5128-35. PubMed ID: 18566121
    [Abstract] [Full Text] [Related]

  • 22. Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.
    Lehrke M, Lebherz C, Millington SC, Guan HP, Millar J, Rader DJ, Wilson JM, Lazar MA.
    Cell Metab; 2005 May; 1(5):297-308. PubMed ID: 16054077
    [Abstract] [Full Text] [Related]

  • 23. Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR.
    Henry-Berger J, Mouzat K, Baron S, Bernabeu C, Marceau G, Saru JP, Sapin V, Lobaccaro JM, Caira F.
    Biol Reprod; 2008 Jun; 78(6):968-75. PubMed ID: 18276933
    [Abstract] [Full Text] [Related]

  • 24. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements.
    Cagen LM, Deng X, Wilcox HG, Park EA, Raghow R, Elam MB.
    Biochem J; 2005 Jan 01; 385(Pt 1):207-16. PubMed ID: 15330762
    [Abstract] [Full Text] [Related]

  • 25. On the role of liver X receptors in lipid accumulation in adipocytes.
    Juvet LK, Andresen SM, Schuster GU, Dalen KT, Tobin KA, Hollung K, Haugen F, Jacinto S, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI.
    Mol Endocrinol; 2003 Feb 01; 17(2):172-82. PubMed ID: 12554745
    [Abstract] [Full Text] [Related]

  • 26. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S, Shima A, Hiroshima A, Koieyama T, Terasaka N.
    Biochim Biophys Acta; 2011 Dec 01; 1811(12):1136-45. PubMed ID: 21875689
    [Abstract] [Full Text] [Related]

  • 27. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
    Liu QY, Quinet E, Nambi P.
    Mol Cell Biochem; 2007 Aug 01; 302(1-2):203-13. PubMed ID: 17396233
    [Abstract] [Full Text] [Related]

  • 28. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.
    Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, Tontonoz P.
    J Biol Chem; 2002 Mar 29; 277(13):11019-25. PubMed ID: 11790787
    [Abstract] [Full Text] [Related]

  • 29. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
    Zhang X, Zhu Z, Luo G, Zheng L, Nilsson-Ehle P, Xu N.
    Biochem Biophys Res Commun; 2008 Jun 20; 371(1):114-7. PubMed ID: 18413148
    [Abstract] [Full Text] [Related]

  • 30. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1.
    Imayama I, Ichiki T, Patton D, Inanaga K, Miyazaki R, Ohtsubo H, Tian Q, Yano K, Sunagawa K.
    Hypertension; 2008 Jun 20; 51(6):1631-6. PubMed ID: 18443233
    [Abstract] [Full Text] [Related]

  • 31. [Activation of liver X receptor regulates fatty acid synthase expression in diabetic liver].
    Wang B, Cheng LJ, Gao ZN, Zhang XY, Huo M, Zhang DJ, Wu J, Wei MF.
    Zhonghua Yi Xue Za Zhi; 2008 Mar 25; 88(12):848-52. PubMed ID: 18756992
    [Abstract] [Full Text] [Related]

  • 32. Regulation of the angiopoietin-like protein 3 gene by LXR.
    Kaplan R, Zhang T, Hernandez M, Gan FX, Wright SD, Waters MG, Cai TQ.
    J Lipid Res; 2003 Jan 25; 44(1):136-43. PubMed ID: 12518032
    [Abstract] [Full Text] [Related]

  • 33. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY, Ou X, Hao XR, Cao DL, Tang YL, Hu YW, Li XX, Tang CK.
    J Cardiovasc Pharmacol; 2008 May 25; 51(5):467-75. PubMed ID: 18437096
    [Abstract] [Full Text] [Related]

  • 34. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T.
    J Lipid Res; 2009 Feb 25; 50(2):301-11. PubMed ID: 18757914
    [Abstract] [Full Text] [Related]

  • 35. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
    Peng D, Hiipakka RA, Dai Q, Guo J, Reardon CA, Getz GS, Liao S.
    J Pharmacol Exp Ther; 2008 Nov 25; 327(2):332-42. PubMed ID: 18723776
    [Abstract] [Full Text] [Related]

  • 36. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F, Leppanen O, Takata Y, Caglayan E, Liu J, Fishbein MC, Kappert K, Nakayama KI, Collins AR, Fleck E, Hsueh WA, Law RE, Bruemmer D.
    Circ Res; 2004 Dec 10; 95(12):e110-23. PubMed ID: 15539633
    [Abstract] [Full Text] [Related]

  • 37. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S, Born E, Mathur SN, Field FJ.
    J Lipid Res; 2002 Jul 10; 43(7):1054-64. PubMed ID: 12091489
    [Abstract] [Full Text] [Related]

  • 38. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors.
    Walczak R, Joseph SB, Laffitte BA, Castrillo A, Pei L, Tontonoz P.
    J Biol Chem; 2004 Mar 12; 279(11):9905-11. PubMed ID: 14699103
    [Abstract] [Full Text] [Related]

  • 39. Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells.
    Wente W, Brenner MB, Zitzer H, Gromada J, Efanov AM.
    Endocrinology; 2007 Apr 12; 148(4):1843-9. PubMed ID: 17194744
    [Abstract] [Full Text] [Related]

  • 40. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.
    Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC, Walter M, Roth MG, Lazo JS.
    J Biol Chem; 2005 Feb 11; 280(6):4079-88. PubMed ID: 15557325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.